Table 5: Comparison of the predictive power among phospho-Her2/neu, phospho-EGFR, and phospho-Her2/neu/phospho-EGFR in breast cancer survival assessment on this study cohort (N=235). P value represents the statistical significance of the improvement over the control analysis

Analysis Age ER PR Her2/neu pHer2/neu EGFR pEGFR F-measure Improvement
1 x x x 0.514
2 x x x x 0.554 p < 0.19
3 x x x x 0.533 p < 0.34
4 x x x x x 0.590 p < 0.05